Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

A male with aromatase deficiency improved bone health with estradiol treatment.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Finasteride shows promise for female hair loss, but more research needed.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.